The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

On-Demand Educational Webinars
Consider how the four emerging themes on purchased services and their leading practices can deliver improved margins.
AHRMM20+ Cost, Quality and Outcomes (CQO) Summit white paper describes lessons learned by health care supply chain during the COVID-19 pandemic, best…
On-Demand Educational Webinars
Achieve cost savings through methods to increase clinical buy-in and adherence to supply chain decision. while maintaining a focus on clinical…
e-Learning
Updated for 2020! Begin your studies of the Supply Chain Management and Finance relationship portion within the CMRP examination with a new…
On-Demand Educational Webinars
Senior leaders within the finance/supply chain and risk management disciplines share their thoughts on the organizational and patient risks related…
On-Demand Educational Webinars
COVID-19 has forced us all to embrace and rely on virtual technology to conduct business. This sudden change has impacted supply chain operations and…